Goldenwell Biotech, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+22.8% +$41K
$220K
Current Assets
—
Cash & Equivalents
$26K
Receivables
$0
Inventory↑+0.1% +$111
$175K
Intangibles
—
Total Liabilities↑+58.7% +$117K
$315K
Current Liabilities
$39K
Account Payables
$0
Long-Term Debt
$176K
Stockholders Equity↓-592.9% -$114K
$-95K
Retained Earnings↓-5.7% -$76K
$-1M
Operating Lease ROU Asset
$0
Operating Lease Liability
$0